Strata Critical Medical (SRTA) Stock Price, News & Analysis

Company Overview

Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

Key Stats

• Today's Range: $4.80 to $5.05
• 50-Day Range: N/A
• 52-Week Range: $2.72 to $6.02
• Volume: 1.03 million shs
• Average Volume: 806,590 shs
• Market Capitalization: $419.29 million
• P/E Ratio: 9.84
• Dividend Yield: N/A
• Price Target: $8.00
• Consensus Rating: Moderate Buy

Strata Critical Medical Stock Analysis - MarketRank™

Strata Critical Medical scored higher than 45% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Strata Critical Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and no sell ratings.

Upside Potential

Strata Critical Medical has a consensus price target of $8.00, representing about 66.0% upside from its current price of $4.82.

Amount of Analyst Coverage

Strata Critical Medical has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Strata Critical Medical is 9.84, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.55.

Price to Book Value per Share Ratio

Strata Critical Medical has a P/B Ratio of 1.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SRTA.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Strata Critical Medical does not currently pay a dividend.

Dividend Growth

Strata Critical Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Strata Critical Medical this week, compared to 2 articles on an average week.

Search Interest

Only 5 people have searched for SRTA on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.

MarketBeat Follows

1 people have added Strata Critical Medical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Strata Critical Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

15.50% of the stock of Strata Critical Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

47.36% of the stock of Strata Critical Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SRTA Stock Analysis - Frequently Asked Questions

How have SRTA shares performed this year?

Strata Critical Medical's stock was trading at $4.38 on January 1st, 2026. Since then, SRTA shares have increased by 10.0% and is now trading at $4.82.

Who are Strata Critical Medical's major shareholders?

Strata Critical Medical's top institutional investors include Sumitomo Mitsui Trust Group Inc. (1.90%), Bank of New York Mellon Corp (1.24%), Principal Financial Group Inc. (0.15%) and Seelaus Asset Management LLC (0.03%).

How do I buy shares of Strata Critical Medical?

Shares of SRTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Transportation, Communications, Electric, Gas, And Sanitary Services
• Industry: Air Transportation
• Sub-Industry: Transportation
• Current Symbol: NASDAQ:SRTA
• CIK: 1779128
• Web: N/A
• Phone: (212) 967-1009
• Fax: N/A
• Employees: 130
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Strata Critical Medical: $8.00
• High Price Target: $8.00
• Low Price Target: $8.00
• Potential Upside/Downside: +66.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.49
• Trailing P/E Ratio: 9.84
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $41.35 million
• Net Margins: 20.97%
• Pretax Margin: -10.18%
• Return on Equity: -5.92%
• Return on Assets: -5.09%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.38
• Quick Ratio: 6.38

Sales & Book Value

• Annual Sales: $197.14 million
• Price / Sales: 2.13
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.22 per share
• Price / Book: 1.50

Miscellaneous

• Outstanding Shares: 86,990,000
• Free Float: 73,506,000
• Market Cap: $419.29 million
• Optionable: N/A
• Beta: 2.15